ID   UL-3B
AC   CVCL_C3SA
DR   Wikidata; Q116050699
RX   PubMed=9412727;
CC   Doubling time: 30 hours (PubMed=9412727).
CC   Donor information: Established during chemotherapy.
CC   Miscellaneous: This cell line was originally classified as originating from an ovarian serous surface papillary adenocarcinoma and has been reclassified as a peritoneal serous papillary adenocarcinoma The reason being that serous surface papillary adenocarcinoma is no longer considered an ovarian primary tumor. The assumption is that all cases have peritoneal primaries.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C7695; Primary peritoneal serous papillary adenocarcinoma
DI   ORDO; Orphanet_168829; Primary peritoneal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C3S9 ! UL-3A
OI   CVCL_C3SB ! UL-3C
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 5
//
RX   PubMed=9412727; DOI=10.1111/j.1600-0897.1997.tb00323.x;
RA   Yashar, Catheryn M.
RA   Taylor, Douglas D.
RA   Gibb, Randall K.
RA   Gercel-Taylor, Cicek
RT   "Lymphokine-activated killer (LAK)-mediated lysis of sequentially
RT   isolated ovarian cancer cell lines.";
RL   Am. J. Reprod. Immunol. 38:431-437(1997).
//